Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anand A Patel

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|March 12, 2023
SOHO State of the Art Updates and Next Questions | Accelerated Phase of MPN: What It Is and What to Do About ItAnand A Patel, Olatoyosi Odenike
Current Hematologic Malignancy Reports|August 12, 2020
The Next Generation of JAK Inhibitors: an Update on Fedratinib, Momelotonib, and PacritinibAnand A Patel, Olatoyosi Odenike
Hematology. American Society of Hematology. Education Program|December 4, 2020
Genomics of MPN progressionAnand A Patel, Olatoyosi Odenike
Hematology/Oncology Clinics of North America|June 27, 2020
Clinical and Biological Prognostic Factors in Follicular LymphomaAnand A Patel, Sonali M Smith
Haematologica|October 24, 2024
Prevention and treatment of transformation of myeloproliferative neoplasms to acute myeloid leukemiaAnand A Patel, Raajit K Rampal
Clinical Lymphoma, Myeloma & Leukemia|March 6, 2025
SOHO State of the Art Updates and Next Questions | Challenging Scenarios in the Management of Myeloproliferative NeoplasmsJoseph Cannova, Shiv Shah, Anand A Patel
Current Opinion in Hematology|January 7, 2026
Contemporary data in myeloproliferative neoplasm-unclassifiable: mutational landscape and management of the 'unclassifiable'Artem Oganesyan, Rafael Madero-Marroquin, Anand A Patel
Blood Advances|April 27, 2021
Cedazuridine/decitabine: from preclinical to clinical development in myeloid malignanciesAnand A Patel, Kirk Cahill, Caner Saygin, et al.
Current Treatment Options in Oncology|May 30, 2020
Biology and Treatment Paradigms in T Cell Acute Lymphoblastic Leukemia in Older Adolescents and AdultsAnand A Patel, Joseph Thomas, Alexandra E Rojek, et al.
Current Treatment Options in Oncology|May 30, 2024
Treatment of Anemia in Lower-Risk Myelodysplastic SyndromeMuriel R Battaglia, Joseph Cannova, Rafael Madero-Marroquin, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Clinical Lymphoma, Myeloma & Leukemia|March 12, 2023
SOHO State of the Art Updates and Next Questions | Accelerated Phase of MPN: What It Is and What to Do About ItAnand A Patel, Olatoyosi Odenike
Current Hematologic Malignancy Reports|August 12, 2020
The Next Generation of JAK Inhibitors: an Update on Fedratinib, Momelotonib, and PacritinibAnand A Patel, Olatoyosi Odenike
Hematology. American Society of Hematology. Education Program|December 4, 2020
Genomics of MPN progressionAnand A Patel, Olatoyosi Odenike
Hematology/Oncology Clinics of North America|June 27, 2020
Clinical and Biological Prognostic Factors in Follicular LymphomaAnand A Patel, Sonali M Smith
Haematologica|October 24, 2024
Prevention and treatment of transformation of myeloproliferative neoplasms to acute myeloid leukemiaAnand A Patel, Raajit K Rampal
Clinical Lymphoma, Myeloma & Leukemia|March 6, 2025
SOHO State of the Art Updates and Next Questions | Challenging Scenarios in the Management of Myeloproliferative NeoplasmsJoseph Cannova, Shiv Shah, Anand A Patel
Current Opinion in Hematology|January 7, 2026
Contemporary data in myeloproliferative neoplasm-unclassifiable: mutational landscape and management of the 'unclassifiable'Artem Oganesyan, Rafael Madero-Marroquin, Anand A Patel
Blood Advances|April 27, 2021
Cedazuridine/decitabine: from preclinical to clinical development in myeloid malignanciesAnand A Patel, Kirk Cahill, Caner Saygin, et al.
Current Treatment Options in Oncology|May 30, 2020
Biology and Treatment Paradigms in T Cell Acute Lymphoblastic Leukemia in Older Adolescents and AdultsAnand A Patel, Joseph Thomas, Alexandra E Rojek, et al.
Current Treatment Options in Oncology|May 30, 2024
Treatment of Anemia in Lower-Risk Myelodysplastic SyndromeMuriel R Battaglia, Joseph Cannova, Rafael Madero-Marroquin, et al.
Pageof 5